Overview Request Sample Pages Request Customization Download PDF
You are viewing: Netherlands Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The Netherlands Gastrointestinal Stent Market was valued at $7.1 Million in 2026 and projected to reach to $8.43 Million by 2031, representing a compound annual growth rate of 3.5%. The Netherlands gastrointestinal stent market is positioned for steady growth driven by an aging population with increasing gastrointestinal complications and a healthcare system prioritizing minimally invasive procedures.

Netherlands Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Netherlands Gastrointestinal Stent Market Trends and Insights

  • In the Netherlands, this moderate growth trajectory reflects steady demand for minimally invasive endoscopic procedures and an aging population requiring gastrointestinal interventions.
  • The Netherlands benefits from advanced healthcare infrastructure and high adoption rates of innovative medical devices, positioning it as a mature market within Europe. Driving growth in the Netherlands are increasing prevalence of gastrointestinal disorders, rising healthcare expenditure, and strong reimbursement frameworks that support stent adoption.
  • The Netherlands' healthcare system emphasizes cost-effective treatment solutions, which favors the use of gastrointestinal stents over surgical alternatives.
  • Between 2026 and 2031, the Netherlands market will be shaped by technological advancements in stent design, growing endoscopic expertise among Dutch clinicians, and expanding applications in biliary and esophageal conditions. The competitive landscape in the Netherlands remains concentrated among established global manufacturers, with local distributors playing a key role in market penetration.
  • The Netherlands' regulatory environment, aligned with European Medical Device Regulation (MDR), ensures high product quality standards and supports market confidence in gastrointestinal stent therapies..

Key Market Statistics

  • CAGR (2026-2031) 3.5% CAGR
  • Market Size, 2026 ~USD 7.1 Million
  • Forecast, 2031 ~USD 8.43 Million
  • Country Netherlands

Netherlands Gastrointestinal Stent Market Overview

Market Valuation :

The Netherlands gastrointestinal stent market is valued at USD 7.1 million in 2026, with projected growth to USD 8.43 million by 2031, representing a steady expansion in minimally invasive endoscopic procedures.

Aging Population Demand :

The Netherlands' aging demographic drives consistent demand for gastrointestinal interventions, with an increasing prevalence of conditions requiring stent placement among elderly patients seeking advanced treatment options.

Healthcare Infrastructure :

The Netherlands boasts a well-developed healthcare system with high adoption rates of advanced endoscopic technologies, supporting the integration of innovative gastrointestinal stent solutions across hospitals and specialized clinics.

Moderate Growth Trajectory :

At a CAGR of 3.5%, the Netherlands market demonstrates stable, sustainable growth compared to the global rate of 5.7%, reflecting mature market dynamics and established clinical practices in gastrointestinal care.

Netherlands Gastrointestinal Stent Market Dynamics

  • The country's advanced medical infrastructure and high healthcare spending support continued adoption of innovative stent technologies.
  • Over the forecast period to 2031, demand will be sustained by rising incidence of esophageal, biliary, and colorectal conditions requiring endoscopic intervention.
  • Healthcare providers in the Netherlands are increasingly investing in state-of-the-art endoscopy equipment, creating favorable conditions for premium stent products.
  • However, market growth remains moderate compared to global rates, reflecting market maturity and established treatment protocols..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The Netherlands GI stent market is valued at USD 7.1 million in 2026 and will reach USD 8.43 million by 2031 at a 3.5% CAGR.
    • The Netherlands' mature healthcare system and strong reimbursement policies drive steady adoption of gastrointestinal stents as minimally invasive alternatives.
    • An aging Dutch population and rising prevalence of GI disorders support consistent demand for stent-based interventions through 2031.
    • The Netherlands market is characterized by established global competitors and local distributors operating within a stringent European regulatory framework.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    Netherlands Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    NETHERLANDS: GASTROINTESTINAL STENTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    AMBULATORY SURGICAL CENTERS0.660.680.710.740.770.80.830.864
    HOSPITALS & CLINICS4.564.684.824.965.125.285.455.643.2
    SPECIALTY ENDOSCOPY CENTERS/GI CLINICS1.461.521.571.641.71.771.851.934.1
    TOTAL6.686.887.17.347.597.858.138.433.5

    Target Audience

    • Medical Device Manufacturers : Gastrointestinal stent manufacturers need Netherlands-specific market data to assess market size, growth potential, and competitive positioning for product launches and market expansion in this developed healthcare economy.
    • Healthcare Investors & PE Firms : Investment professionals require detailed Netherlands market analysis to evaluate acquisition targets, portfolio company growth prospects, and return potential in the gastrointestinal medical device sector.
    • Hospital & Clinic Administrators : Healthcare facility leaders need market insights to inform procurement decisions, budget allocation for endoscopy departments, and technology adoption strategies aligned with patient demand trends.
    • Market Research & Consulting Firms : Research organizations require granular Netherlands market data to support client advisory services, competitive benchmarking, and strategic recommendations in the gastrointestinal device market.
    • Regulatory & Compliance Professionals : Regulatory specialists need Netherlands-specific market intelligence to understand local approval pathways, reimbursement mechanisms, and healthcare policy requirements for gastrointestinal stent products.

    Key Companies in the Netherlands Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Reasons to Buy this Report

    • Country-Specific Market Sizing : Obtain precise market valuation data for the Netherlands GI stent market with accurate 2026-2031 forecasts, enabling targeted investment and expansion decisions in this mature European healthcare market.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to the Netherlands healthcare system, including key players, market share distribution, and differentiation strategies among gastrointestinal stent manufacturers.
    • Regulatory & Reimbursement Insights : Access Netherlands-specific regulatory requirements, reimbursement pathways, and healthcare policy frameworks that directly impact product commercialization and market penetration strategies.
    • Demographic & Clinical Trends : Leverage detailed analysis of the Netherlands' aging population demographics, disease prevalence patterns, and clinical practice preferences to align product development with local market needs.
    • Strategic Market Entry Planning : Develop informed go-to-market strategies for the Netherlands with localized insights on healthcare provider preferences, distribution channels, and growth opportunities in this high-income healthcare market.

    Frequently asked questions

    What is the current size of the gastrointestinal stent market in the Netherlands?

    The Netherlands gastrointestinal stent market is valued at USD 7.1 million in 2026.

    What is the projected market size for gastrointestinal stents in the Netherlands by 2031?

    The Netherlands gastrointestinal stent market is projected to reach USD 8.43 million by 2031.

    What is the CAGR for the gastrointestinal stent market in the Netherlands?

    The Netherlands gastrointestinal stent market is expected to grow at a compound annual growth rate (CAGR) of 3.5% from 2026 to 2031.

    What factors are driving growth in the Netherlands gastrointestinal stent market?

    Growth in the Netherlands is driven by an aging population, increasing prevalence of gastrointestinal disorders, strong healthcare reimbursement, and preference for minimally invasive endoscopic procedures.

    How does the Netherlands regulatory environment affect the gastrointestinal stent market?

    The Netherlands operates under the European Medical Device Regulation (MDR), which ensures high product quality standards and supports market confidence in gastrointestinal stent therapies.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status